Fisher & Paykel Healthcare Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Fisher & Paykel Healthcare wird ein jährliches Gewinn- und Umsatzwachstum von 23.9% bzw. 10.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 23.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 22.9% betragen.

Wichtige Informationen

24.7%

Wachstumsrate der Gewinne

24.3%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	20.0%
Wachstumsrate der Einnahmen	10.8%
Zukünftige Eigenkapitalrendite	24.0%
Analystenabdeckung	Good
Zuletzt aktualisiert	27 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Aug 21

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Jul 29

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Jul 11

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected

Jun 22

There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings

Jun 05

Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Mar 27

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Feb 22

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price

Feb 05

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate

Jan 03

We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Nov 30

Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital

Nov 12

Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Aug 28

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Aug 10

Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly

Jul 02

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

May 01

Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)

Jan 23

Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Dec 27

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Oct 28

Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value

Oct 13

Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet

Sep 28

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Jul 24

A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

Jul 10

Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly

Jun 12

A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Apr 17

Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention

Dec 26

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Dec 05

This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation

Aug 11

Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?

Aug 01

Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?

Jul 07

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Jun 24

Gewinn- und Umsatzwachstumsprognosen

NZSE:FPH - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (NZD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	2,499	521	385	621	14
3/31/2026	2,231	434	291	540	15
3/31/2025	1,988	359	314	471	15
3/31/2024	1,743	133	91	430	N/A
12/31/2023	1,719	197	61	411	N/A
9/30/2023	1,694	262	31	393	N/A
6/30/2023	1,638	256	29	316	N/A
3/31/2023	1,581	250	27	238	N/A
12/31/2022	1,527	251	6	218	N/A
9/30/2022	1,472	251	-15	199	N/A
6/30/2022	1,577	314	70	262	N/A
3/31/2022	1,682	377	155	324	N/A
12/31/2021	1,821	449	259	430	N/A
9/30/2021	1,961	521	363	535	N/A
6/30/2021	1,966	522	402	580	N/A
3/31/2021	1,971	524	441	625	N/A
12/31/2020	1,787	458	344	526	N/A
9/30/2020	1,603	392	247	426	N/A
6/30/2020	1,433	339	199	374	N/A
3/31/2020	1,264	287	151	321	N/A
12/31/2019	1,197	260	133	297	N/A
9/30/2019	1,130	233	115	273	N/A
6/30/2019	1,100	221	117	263	N/A
3/31/2019	1,070	209	120	253	N/A
12/31/2018	1,052	208	135	256	N/A
9/30/2018	1,034	206	151	259	N/A
6/30/2018	1,007	198	150	253	N/A
3/31/2018	981	190	149	248	N/A
12/31/2017	954	181	N/A	224	N/A
9/30/2017	928	172	N/A	200	N/A
6/30/2017	911	171	N/A	197	N/A
3/31/2017	894	169	N/A	194	N/A
12/31/2016	877	164	N/A	190	N/A
9/30/2016	860	160	N/A	186	N/A
6/30/2016	838	152	N/A	165	N/A
3/31/2016	815	143	N/A	145	N/A
12/31/2015	776	135	N/A	135	N/A
9/30/2015	736	126	N/A	126	N/A
6/30/2015	704	120	N/A	136	N/A
3/31/2015	672	113	N/A	147	N/A
12/31/2014	655	107	N/A	134	N/A
9/30/2014	637	101	N/A	122	N/A
6/30/2014	630	99	N/A	111	N/A
3/31/2014	623	97	N/A	100	N/A
12/31/2013	608	93	N/A	94	N/A
9/30/2013	593	88	N/A	88	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: FPHDas prognostizierte Gewinnwachstum (23.9% pro Jahr) liegt über der Sparquote (2.7%).

Ertrag vs. Markt: FPHDie Erträge des Unternehmens (23.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt NZ (19% pro Jahr).

Hohe Wachstumserträge: FPHEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: FPHDie Einnahmen des Unternehmens (10.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt NZ (4.8% pro Jahr).

Hohe Wachstumseinnahmen: FPHDie Einnahmen des Unternehmens (10.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: FPHDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (22.9%)

Fisher & Paykel Healthcare Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 7.3% to NZ$27.77

Price target increased by 7.0% to NZ$23.63

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of 2024

Consensus EPS estimates fall by 14%

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2024

Price target increased by 7.4% to NZ$23.89

Recent updates

Insider recently sold NZ$1.3m worth of stock

MD, CEO & Executive Director recently sold NZ$1.8m worth of stock

Price target increased by 7.3% to NZ$27.77

Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns

Fisher & Paykel Healthcare Corporation Limited Announces Board and Committee Changes

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected

Upcoming dividend of NZ$0.28 per share

Fisher & Paykel Healthcare Corporation Limited, Annual General Meeting, Aug 28, 2024

There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings

Final dividend of NZ$0.28 announced

Full year 2024 earnings: EPS misses analyst expectations

Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Price target increased by 7.0% to NZ$23.63

Fisher & Paykel Healthcare Corporation Limited to Report Fiscal Year 2024 Results on May 29, 2024

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

First half 2024 earnings: EPS exceeds analyst expectations

We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Fisher & Paykel Healthcare Corporation Limited Approves Interim Dividend, Payable on 18 December 2023

Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital

Fisher & Paykel Healthcare Corporation Limited to Report First Half, 2024 Results on Nov 29, 2023

Fisher & Paykel Healthcare Corporation Limited Announces Launch of F&P Solo Mask in New Zealand and Australia for Treatment of Obstructive Sleep Apnea

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of 2024

Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Fisher & Paykel Healthcare Corporation Limited Announces Board Changes

Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly

Upcoming dividend of NZ$0.27 per share at 1.6% yield

Fisher & Paykel Healthcare Corporation Limited, Annual General Meeting, Aug 29, 2023

Consensus EPS estimates fall by 14%

Full year 2023 earnings released: EPS: NZ$0.43 (vs NZ$0.65 in FY 2022)

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the Year 2024

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Vice President of Products & Technology exercised options to buy NZ$194k worth of stock.

Price target increased by 7.4% to NZ$23.89

Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)

Consensus EPS estimates increase by 11%

Fisher & Paykel Healthcare Corporation Limited Provides Revenue Guidance for the Financial Year Ending 31 March 2023

Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Price target increased to NZ$22.88

Price target increased to NZ$22.79

Investor sentiment improved over the past week

First half 2023 earnings: EPS and revenues exceed analyst expectations

Fisher & Paykel Healthcare Corporation Limited Announces Ordinary Distribution for the Six Months Ended September 30, 2022, Payable on December 21, 2022

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value

Independent Non-Executive Director recently bought NZ$58k worth of stock

Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet

Independent Non-Executive Director recently bought NZ$108k worth of stock

Fisher & Paykel Healthcare Corporation Limited to Report First Half, 2023 Results on Nov 29, 2022

Price target decreased to NZ$21.30

Consensus EPS estimates fall by 29%

Fisher & Paykel Healthcare Corporation Limited Provides Earnings Guidance for the First Half of Fiscal Year 2023

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

Fisher & Paykel Healthcare Announces Management Changes

Fisher & Paykel Healthcare Corporation Limited Declares Ordinary Dividend for the Six Months Period Ended March 31, 2022, Payable on July 6, 2022

Upcoming dividend of NZ$0.26 per share

Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly

Consensus EPS estimates fall by 15%

Fisher & Paykel Healthcare Corporation Limited Appoints Cather Simpson as Non-Executive Director, Effect 1 June 2022

Price target decreased to NZ$23.98

Full year 2022 earnings: EPS in line with expectations, revenues disappoint